日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The oncogenic CCDC6-RET fusion protein is a dual ATP- and ADP-dependent kinase

致癌的CCDC6-RET融合蛋白是一种双重ATP和ADP依赖性激酶。

Martín-Hurtado, Ana; Contreras, Julia; Sánchez-Wandelmer, Jana; Zarzuela, Eduardo; García, Fernando; Le Coq, Johanne; Boskovic, Jasminka; Muñoz, Inés G; Gago, Federico; Muñoz, Javier; Isasa, Marta; Plaza-Menacho, Iván

PRDM1 restricts bladder cancer progression and enhances chemosensitivity by suppressing OTUD6A-mediated deubiquitination of CDC6.

PRDM1 通过抑制 OTUD6A 介导的 CDC6 去泛素化来限制膀胱癌的进展并增强化疗敏感性。

Cui Jianfeng, Chen Shouzhen, Liu Xiaochen, Jiang Xuewen, Cheng Guangzhou, Liu Zhifeng, Zhao Hui, Zhu Yaofeng, Shi Benkang, Zou Yongxin

CircCCDC66 promotes the progression and EMT of renal cell carcinoma via the miR-1278/HOXA13 axis

CircCCDC66通过miR-1278/HOXA13轴促进肾细胞癌的进展和EMT。

Peng, Zheng; Wang, Qing; Huang, Kunyuan; Chen, Xiaolong; Deng, Guanyun; Luo, Jinyu; Zhu, Jianguo; Jiang, Kehua

RET-Targeted Neoadjuvant Therapy Enables Curative Surgery in an Ultra-Elderly Patient With Recurrent Colon Cancer Harboring a CCDC6-RET Fusion

RET靶向新辅助疗法使携带CCDC6-RET融合基因的复发性结肠癌超高龄患者得以进行根治性手术

Jin, Tianhao; Cricri, Michele; Chen, Xin; He, Jinjie; Liu, Yue

Genetic Influence of CCDC63 Polymorphisms on Alcohol-Induced Dyslipidemia in a Korean Cohort

CCDC63多态性对韩国人群酒精性血脂异常的遗传影响

Kim, Yu-Na; Lee, Sung Won; Jin, Hyun-Seok; Park, Sangwook

A YAP/TAZ-CDC6 Axis Initiates and Maintains Malignant Transformation

YAP/TAZ-CDC6轴启动并维持恶性转化

Nduru, David; Ohta, Yudai; Nita, Akihiro; Niimura, Mayumi; Ngurari, Samson; Moroishi, Toshiro

Correction: RPL28 mediates sorafenib resistance in hepatocellular carcinoma by downregulating CDC6 expression

更正:RPL28通过下调CDC6表达介导肝细胞癌的索拉非尼耐药性。

Shi, Yi; Chen, Fangfang; Weng, Yuanyuan; Zeng, Hang; Chen, Gang

RPL28 mediates sorafenib resistance in hepatocellular carcinoma by downregulating CDC6 expression

RPL28通过下调CDC6表达介导肝细胞癌的索拉非尼耐药性。

Shi, Yi; Chen, Fangfang; Weng, Yuanyuan; Zeng, Hang; Chen, Gang

Loss of WT1 Drives Adaptive Plasticity in CCDC6-RET Selpercatinib-Resistant Papillary Thyroid Cancer.

WT1 的缺失驱动 CCDC6-RET 耐塞帕替尼的乳头状甲状腺癌的适应性可塑性。

Siragusa Giuseppe, Tomasello Laura, Biondo Mattia, Vaglica Fabiola, Giordano Carla, Arnaldi Giorgio, Pizzolanti Giuseppe

Therapeutic efficacy monitoring in canine lymphoma patients via quantifying CDC6 plasma levels

通过定量检测血浆中 CDC6 水平来监测犬淋巴瘤患者的治疗效果

Seijger, Anne; Musi, Alice; Zandvliet, Maurice M J M; Kuipers, Marije E; Lak, Nathalie S M; van der Steen, Francine E M M; Rinaldi, Valentina; Feenstra, Laurien R; Tytgat, Godelieve A M; Nolte-'t Hoen, Esther N M; Bongiovanni, Laura; de Bruin, Alain